Skip to main content
Have a personal or library account? Click to login
Prevalence of papillary thyroid cancer in subacute thyroiditis patients may be higher than it is presumed: retrospective analysis of 137 patients Cover

Prevalence of papillary thyroid cancer in subacute thyroiditis patients may be higher than it is presumed: retrospective analysis of 137 patients

Open Access
|Sep 2018

Figures & Tables

Figure 1

Haematoxylin and eosin stained sections of Case 4 (A), Case 5 (B) and Case 6 (C). Follicular atrophy and fibrosis, fibrosis accompanied by chronic inflammatory cells and fibrosis are seen, respectively.

Table 1

Demographic characteristics and laboratory findings at disease onset of patients with subacute thyroiditis and papillary thyroid cancer

CasesAgeSexFT3 (pmol/L) (3.1–6.8)FT4 (pmol/L) (12–22)TSH (miU/L) (0.27–4.2)CRP (mg/L) (0–5)ESR (mm/h) (0–20)Tc 99m /RAI Uptake (%) (0.3–3 vs. 20–50)Ultrasonography
142FNA19.90.2NA55Low/0.23.2 cm hypoechoic nodule
256F6.7326.30.009NA340.06/1.35Diffuse HEAs, 2.2 cm hypo-isoechoic nodule
356F4.521.10.68125.01000.59/NA focal hypoactivity1.8 cm focal HEA, 0.7 cm hypoechoic nodule with microcalcification
451MNA44.20.01NA91Low/NAFocal HEAs, 1.6 cm isoechoic nodule
552F7.0124.70.0215.660Low/NA2.4 cm heterogenous nodule with calcification and 1.1 cm isoechoic nodule
645F13450.005138.8132Low/NA2.2 cm hypoechoic, 1.9 cm isoechoic nodules

CRP =C-reactive protein; ESR = erythrocyte sedimentation rate; F = female; FT3 = free triiodothyronine; FT4 = free thyroxine; HEA = hypoechogenic area; M = male; NA, not available; RAI = radioactive iodine; Tc 99m = Technetium-99m; TSH = thyroid-stimulating hormone

∗ All of the patients had Technetium-99m scintigraphy, additionally some of them had either Technetium-99m uptake or 24-h RAI uptake.

Table 2

Presurgical ultrasonographic findings and histopathologic features of subacute thyroiditis patients with papillary thyroid cancer

CasesOp.Time(mo)Nodule size in USG (cm)Sonographic features of nodulesFNABTumor subtype/HistologyTumor size (cm)Stage (8th TNM)Treatment
11070.55 and 0.50Hypoechoic, indefinite marginsSuspicious for malignancyPapillary-tall cell and classical
Focal fibrosis
0.5 and 0.05ITT+RAI
2132.4 and 1.0Hypo-isoechoic, calcificationDyskaryotic thyrocytesPapillary-classical
Chronic lymphocytic thyroiditis
1.0ITT+RAI
3290.7Hypoechoic, microcalcificationFLUS Suspicious for malignancyPapillary-follicular variant
Fibrosis, chronic lymphocytic thyroiditis
0.6ITT
4161.9IsoechoicSuspicious for malignancyPapillary-follicular variant
Fibrosis, focal follicular atrophy
0.4ILobectomy
5131.1 and 0.73Isoechoic, microcalcificationSuspicious for malignancyPapillary-classical and follicular1.1, 0.7, 0.3, 0.2ITT+ RAI
Fibrosis, chronic lymphocytic thyroiditis
6371.7 and 0.9Hypoechoic and isoechoicAUS Papillary carcinomaPapillary-classical and follicular
Fibrosis
1.2, 0.3, 0.2ITT+RAI

AUS = atypia of undetermined significance; FLUS = follicular lesion of undetermined significance; FNAB = fine needle aspiration biopsy; Op = operation time after the diagnosis of subacute thyroiditis in months; RAI = radioactive iodine; TT = total thyroidectomy; USG = ultrasonography

∗ In patients with more than two nodules, the sizes of the dominant ones are given.

DOI: https://doi.org/10.2478/raon-2018-0027 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 257 - 262
Submitted on: Mar 12, 2018
Accepted on: Jul 12, 2018
Published on: Sep 11, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Nurdan Gül, Ayşe Kubat Üzüm, Özlem Soyluk Selçukbiricik, Gülçin Yegen, Refik Tanakol, Ferihan Aral, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.